BioCryst awarded advanced development funding for BCX4430 to treat Ebola and other filoviruses
1 April 2015 | By Victoria White
BioCryst has announced it has been has awarded a contract for the continued development of BCX4430 as a potential treatment for diseases, including Ebola...